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Abstract: Previous studies suggest that nitric oxide is involved in the regulation of the intraocular
pressure (IOP) and in the pathophysiology of open-angle glaucoma (OAG). However, prospective
studies investigating the association between dietary nitrate intake, a source of nitric oxide, and
incident (i)OAG risk are limited. We aimed to determine the association between dietary nitrate
intake and iOAG, and to evaluate the association between dietary nitrate intake and IOP. From
1991 onwards, participants were followed each five years for iOAG in the Rotterdam Study. A total
of 173 participants developed iOAG during follow-up. Cases and controls were matched on age
(mean ± standard deviation: 65.7 ± 6.9) and sex (%female: 53.2) in a case:control ratio of 1:5. After
adjustment for potential confounders, total dietary nitrate intake was associated with a lower iOAG
risk (odds ratio (OR) with corresponding 95% confidence interval (95% CI): 0.95 (0.91–0.98) for each
10 mg/day higher intake). Both nitrate intake from vegetables (OR (95% CI): 0.95 (0.91–0.98) for
each 10 mg/day higher intake) and nitrate intake from non-vegetable food sources (OR (95% CI):
0.63 (0.41–0.96) for each 10 mg/day higher intake) were associated with a lower iOAG risk. Dietary
nitrate intake was not associated with IOP. In conclusion, dietary nitrate intake was associated with a
reduced risk of iOAG. IOP-independent mechanisms may underlie the association with OAG.
Keywords: open-angle glaucoma; intraocular pressure; dietary nitrate; green-leafy vegetables
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1. Introduction
Glaucoma is an eye disease that causes the most cases of irreversible blindness worldwide. Currently, more than 80 million people worldwide have glaucoma, of which approximately 11 million are estimated to be bilaterally blind [1]. A high intraocular pressure
(IOP) is a well-known modifiable risk factor but, since glaucoma can progress despite
an “adequate” IOP, it is very likely that IOP-independent mechanisms play a role as well.
Therefore, more knowledge about other potential risk factors is urgently needed for optimal
prevention and treatment strategies.
Several studies have investigated the association between nutrition and open-angle
glaucoma (OAG) [2]. Studies on the intake of dark green leafy vegetables showed an inverse association with OAG [3–5]. This may in part be explained by the substantial amount
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of dietary nitrate that green leafy vegetables contain (2000–5000 mg/kg) [6–8], along with
phylloquinone, lutein, folate, α-tocopherol, and kaempferol [9]. Due to the nitrate–nitrite–
nitric oxide pathway, nitrate is an important source of nitric oxide (NO). Different studies
have suggested that NO, known as endothelium-derived relaxing factor [10], plays a role in
the regulation of IOP, by increasing the conventional outflow facility [3,11–15]. Abnormal
function and degradation of endothelial cells are associated with reduced NO bioavailability and, subsequently, progression of glaucoma [16]. Additionally, the endothelium
of Schlemm’s canal (SC) reacts to physiological levels of shear stress, by aligning with
the direction of flow and by increasing the production of NO. NO production by SC cells
has a homeostatic signaling function during times of elevated IOP, when SC narrows
and shear stress on SC cells increases. Shear-stimulated production of NO by SC cells
would then increase outflow facility, normalizing IOP [17–20]. This process may be compromised in glaucoma, as SC cells isolated from glaucomatous eyes have shown to be
either shear-unresponsive or lifted from their substrate in the presence of shear stress [21].
IOP-independent effects of dietary nitrate have also been suggested. Dietary nitrate has
shown to have beneficial effects on blood pressure, endothelial function, reperfusion injury,
and platelet aggregation [22]. All of these may be involved in the pathophysiology of OAG,
but studies investigating whether dietary nitrate intake relates to the risk of incident (i)
OAG are limited.
The aim of this study was to determine the association between dietary nitrate intake
and iOAG. We also examined the association between dietary nitrate intake and IOP, as an
OAG risk factor, and we studied whether potential associations with iOAG were explained
by IOP or, indirectly, by blood pressure.
2. Materials and Methods
2.1. Study Design and Population
Participants were derived from three independent cohorts from the prospective
population-based Rotterdam Study (RS-I, RS-II, RS-III), designed to assess determinants of
age-related diseases in the middle-aged and elderly population (45+ years). Enrollment for
the ophthalmic part started in 1991; after the baseline visit, participants were invited for
follow-up visits with intervals of approximately five years [23]. Of 8679 participants with
ophthalmic examinations, 7008 had baseline measurements of dietary nitrate intake. Of
those, 173 participants developed iOAG during follow-up. Since age is strongly associated
with iOAG risk [24] and dietary intake [25,26], and dietary intake is different for females
compared to males [27], we chose to use a case–control design. We matched cases and
controls on age (maximum difference of three years) and sex, in a 1:5 ratio, and sampled
without replacement. The final dataset consisted of 173 cases and 865 controls.
2.2. Ophthalmic Assessment
The eye examinations included Goldmann applanation tonometry (Haag-Streit AG,
Bern, Switzerland), and visual field testing (Humphrey Field Analyzer; HFA II 740; Carl
Zeiss, Oberkochen, Germany). All participants underwent visual field testing using the
Humphrey Field Analyzer (HFA; Carl Zeiss Meditec, Jena, Germany). A second suprathreshold test was performed when a visual field defect appeared to be present. Details
have been described elsewhere [28]. If the second supra-threshold test showed at least one
overlapping abnormality in the same hemifield, Goldmann kinetic perimetry (RS-I-1 and
RS-I-3; Haag-Streit) or full-threshold HFA (all other cohort visits) was performed on both
eyes. If abnormalities were consecutive and reproducible, thus present on the Goldmann
or full-threshold test and on both supra-threshold tests, visual field loss was considered
to be present. Defects had to be in a consistent hemifield and at least one depressed test
point had to have exactly the same location on all fields. Glaucoma specialists examined
fundus photographs, ophthalmic examination reports, medical histories, and MRI scans
of the brain to exclude all other possible causes of visual field loss. Discrepancies were
resolved by consensus. iOAG cases had an open anterior chamber angle and no history or
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signs of secondary glaucoma [28]. For IOP, three measurements were taken from each eye,
the median value of which was recorded [29]. For iOAG cases, we used IOP measurements
of the affected eye. If both eyes were affected or unaffected, a random eye was selected.
IOP was not included in the definition of iOAG.
2.3. Dietary Nitrate Data
Dietary intake was assessed at baseline using food frequency questionnaires (FFQs)
as described in detail elsewhere [30]. Both FFQs were previously validated and showed
reasonable to good estimates of nutrient intake [31–33]. All food items were assessed
based on the frequency of consumption, the number of servings per day as well as on the
preparation methods. We calculated dietary nitrate intake separately from vegetables and
non-vegetable food sources, because of their possible contradicting health effects [34–39].
Nitrate intake for each vegetable was calculated using a comprehensive database, including nitrate data for 178 vegetables from over 250 publications [40]. Nitrate intake from
vegetables (mg/day) was calculated by multiplying the amount of each vegetable (g/day)
by the median nitrate content (mg/g) for that individual vegetable. Nitrate intake from
non-vegetable food sources was obtained from an earlier developed dietary nitrate and
nitrate database [41]. Nitrate intake from non-vegetable food sources was estimated by
multiplying the amount of the food item (g/day) by the mean nitrate value (mg/g) of that
food item. If no nitrate value was available for a specific food item, we considered a value
of 0 mg/g. Total dietary nitrate intake (mg/day) was calculated by summing the nitrate
intake from vegetables and nitrate intake from non-vegetable food sources. Participants
with unreliable dietary intake (total energy intake <500 kcal/day or >5000 kcal/day) were
excluded.
2.4. Covariates
Education level was assessed with questionnaires and categorized into: primary
education, lower education, intermediate education, or higher education. Smoking status
was obtained using questionnaires and participants were classified as non-smoker, former
smoker or current smoker. At the research center, blood pressure was measured at the
right brachial artery with the participant in sitting position. The mean of two consecutive
measurements was used. Hypertension was defined as a resting blood pressure exceeding
140/90 mmHg or the use of blood pressure-lowering medication. Medication data on
blood pressure-lowering medications (antihypertensives, diuretics, beta blockers, calcium
channel blockers, and renin-angiotensin-aldosterone system agents) were collected with
questionnaires [42]. Weight and height were measured at the research center. Body mass
index (BMI) was calculated as weight in kilograms divided by height in meters squared.
Total energy intake was obtained from the previously described FFQs. Diet quality was
defined as adherence to the Dutch dietary guidelines, with a scoring range from 0 (no
adherence) to 14 (full adherence). Details have been described elsewhere [43]. For physical
activity, two different questionnaires were used: a validated adapted version of the Zutphen
Physical Activity Questionnaire [44] and the LASA Physical Activity Questionnaire [45].
Data were recalculated into metabolic equivalent of task (MET)-hours per week, and a
z-standardized score was included in the analyses.
2.5. Statistical Analyses
Differences in baseline characteristics between cases and controls were evaluated
using chi-square tests and independent-samples t-tests. We adjusted dietary nitrate intake
for total energy intake by applying the nutrient residual method and analyzing the dietary
nitrate intake adjusted for total energy intake. One-way ANOVA was used to compare
the baseline characteristics of participants in the different quintiles of total dietary nitrate
intake. The dose–response relationship between dietary nitrate intake and predicted iOAG
probability or IOP, was examined using generalized additive modelling. We performed
multivariable conditional logistic regression analyses to calculate odds ratios (ORs) with
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corresponding 95% confidence intervals (CI) for iOAG and hypertension. ORs can be
interpreted as the difference in odds per increase of 10 mg/day intake of dietary nitrate
keeping energy intake constant (iso-energetic). Additionally, we modelled dietary nitrate
intake in quintiles with the first quintile (Q1) as reference category to test for evidence
of linear trends. The median value for each category as continuous variables was used
in separate conditional logistic regression models. The final models included BMI, total
energy intake, diet quality, physical activity, and follow-up time. Follow-up duration was
calculated from the baseline until the last visit with reliable ophthalmic examination or
the first visit with iOAG diagnosis. To assess potential reverse causality, we analyzed the
association between dietary nitrate intake and iOAG in cumulative follow-up intervals.
Additionally, we observed the effect of including IOP (potential mediator in the association
with iOAG) or education level and smoking status (lifestyle factors affecting nutrition
quality) in the models. The association of dietary nitrate with IOP at follow-up, and
diastolic and systolic blood pressure at baseline, was assessed by performing multivariable
linear regression analysis, adjusting for the same covariates as mentioned above. The
blood pressure analyses were additionally adjusted for use of blood pressure-lowering
medications. Statistical analyses were performed using SPSS v25.0 (SPSS Inc., Chicago, IL,
USA) and R v3.6.1 (R Inc., Boston, MA, USA), with packages DescTools, mgcv, ggplot2,
dplyr and ggforestplot. A p-value < 0.05 was considered statistically significant.
3. Results
The baseline characteristics of cases and controls are displayed in Table 1. Participants
with iOAG had a significantly lower BMI and their diet quality score was higher. As
expected, they had a significantly higher IOP. Dietary nitrate intake was significantly
different between cases and controls. Baseline characteristics according to quintiles of total
dietary nitrate intake are presented in Table 2. Higher consumers of dietary nitrate more
often had a higher education. Additionally, their BMI, total energy intake and diet quality
score were higher.
Figure 1 presents a graphic representation of the dose–response relationship between dietary nitrate intake, iOAG and IOP analyzed in separate generalized additive
multivariable-adjusted models. For iOAG, similar dose–response relationships were found
for total dietary nitrate intake (Figure 1A), nitrate intake from vegetables (Figure 1B) and
nitrate intake from non-vegetable food sources (Figure 1C), i.e., they were linear across the
reported range of intake. For IOP, a different dose–response relationship was found for
nitrate intake from non-vegetable food sources and IOP (Figure 1F) compared to the relationship with total dietary nitrate intake and nitrate intake from vegetables (Figure 1D,E).
The association of nitrate intake from non-vegetable food sources with IOP was linear
across the reported range of intake, whereas the associations of total dietary nitrate intake
and nitrate intake from vegetables with IOP were not.
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Table 1. Baseline characteristics of participants that did and did not develop incident open-angle
glaucoma (iOAG) during follow-up.
No iOAG (N = 865)

iOAG (N = 173)

p-Value

Age, years, mean (SD)

64.8 (7.0)

65.7 (6.9)

0.12

Sex, female, N (%)

460 (53.2)

92 (53.2)

>0.99

Education, N (%)
Primary education
Lower education
Intermediate education
Higher education

101 (11.7)
376 (43.5)
250 (28.9)
131 (15.1)

21 (12.1)
78 (45.1)
53 (30.6)
21 (12.1)

Smoking status, N (%)
Non-smoker
Former smoker
Current smoker

281 (32.5)
410 (47.4)
170 (19.7)

54 (31.2)
81 (46.8)
38 (21.9)

Hypertension, N (%)

491 (56.8)

92 (53.2)

0.46

SBP, mmHg, mean (SD)

137.6 (20.6)

136.6 (20.9)

0.58

DBP, mmHg, mean (SD)

77.1 (11.6)

75.0 (12.5)

0.03

BMI, kg/m2, mean (SD)

27.1 (4.1)

25.9 (3.3)

<0.001

Total energy intake, kcal/day, mean (SD)

2119.1 (594.5)

2054.3 (515.0)

0.19

Diet quality, mean (SD)

6.6 (1.9)

7.0 (1.9)

0.04

Physical activity, MET hours/week, mean (SD)

0.0 (0.9)

0.1 (0.9)

0.07

IOP, mmHg, mean (SD)

14.1 (2.9)

16.4 (3.9)

<0.001

Follow-up time, years, mean (SD)

9.5 (4.7)

10.9 (5.3)

<0.001

Total dietary nitrate intake, mg/day, mean (SD)

109.8 (78.4)

92.8 (47.1)

<0.001

Nitrate intake from vegetables, mg/day, mean (SD)

94.2 (76.3)

77.4 (45.2)

<0.001

Nitrate intake from non-vegetable food sources,
mg/day, mean (SD)

15.6 (7.9)

15.4 (10.9)

0.78

0.77

0.79

Abbreviations: iOAG, incident open-angle glaucoma; N, number; SBP, systolic blood pressure; DBP, diastolic
blood pressure; BMI, body mass index; MET, metabolic equivalent of task; IOP, intraocular pressure; SD, standard
deviation.

Table 2. Baseline characteristics of participants by energy adjusted total dietary nitrate intake (1st,
3rd, and 5th quintiles).
KERRYPNX

Q1 (N = 205)

Q3 (N = 206)

Q5 (N = 205)

p ANOVA

iOAG, N (%)

38 (18.5)

38 (18.4)

20 (9.8)

0.07

Age, years, mean (SD)

66.4 (7.1)

65.7 (6.9)

62.5 (6.0)

<0.001

Sex, female, N (%)

93 (45.4)

124 (60.2)

119 (58.0)

0.03

Education, N (%)
Primary education
Lower education
Intermediate education
Higher education

31 (15.1)
86 (42.0)
61 (30.0)
24 (11.7)

29 (14.1)
89 (43.2)
58 (28.2)
28 (13.6)

7 (3.4)
94 (45.8)
60 (29.3)
43 (21.0)

Smoking status, N (%)
Non-smoker
Former smoker
Current smoker

69 (33.7)
88 (42.9)
46 (22.4)

75 (36.4)
91 (44.2)
40 (19.4)

60 (29.3)
106 (51.7)
39 (19.0)

Hypertension, N (%)

118 (57.5)

123 (59.7)

118 (57.6)

0.39

SBP, mmHg, mean (SD)

140.8 (20.4)

138.9 (22.9)

137.0 (19.7)

0.04

DBP, mmHg, mean (SD)

77.7 (12.3)

76.5 (12.5)

78.4 (10.6)

0.02

0.005

0.73
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Table 2. Cont.
KERRYPNX

Q1 (N = 205)

Q3 (N = 206)

Q5 (N = 205)

p ANOVA

BMI, kg/m2, mean (SD)

26.3 (3.6)

26.8 (3.9)

28.2 (4.6)

<0.001

Total energy intake, kcal/days, mean (SD)

2233.2 (673.9)

2024.8 (484.4)

2140.5 (569.8)

0.002

Diet quality, mean (SD)

6.0 (1.8)

7.2 (1.8)

7.0 (2.0)

<0.001

Physical activity, MET hours/week, mean
(SD)

−0.1 (0.9)

0.1 (0.9)

0.1 (0.9)

0.06

IOP, mmHg, mean (SD)

14.6 (3.1)

14.6 (3.1)

14.1 (3.4)

0.33

Follow-up time, years, mean (SD)

9.6 (4.5)

10.4 (5.2)

9.2 (4.8)

0.07

Total
dietary
nitrate
intake, mg/day, mean
Nutrients
2022,
14, 2490
(SD)

48.8 (15.7)

86.4 (11.4)

213.0 (91.7)

6 of 14
<0.001

Nitrate intake from vegetables, mg/day,
35.1 (14.5)
71.2 (10.1)
196.8 (91.4)
<0.001
mean (SD)
ported range of intake. For IOP, a different dose–response relationship was found for niNitrate intake from non-vegetable
food
trate
intake from non-vegetable food sources and IOP (Figure 1F) compared to the rela13.7 (4.6)
15.2 (5.7)
16.3 (6.7)
<0.001
sources, mg/day, mean (SD)
tionship with total dietary nitrate intake and nitrate intake from vegetables (Figure 1D,E).
The association
of nitrate
intake
from non-vegetable
food
sources
with
IOP wasglaucoma;
linear SBP,
Abbreviations:
N, number;
Q, quintile;
ANOVA,
analysis of variance;
iOAG,
incident
open-angle
systolic
blood
diastolic
bloodwhereas
pressure; BMI,
body mass index;
MET,
metabolic
equivalent
across
thepressure;
reportedDBP,
range
of intake,
the associations
of total
dietary
nitrate
intakeof task;
IOP,
intraocular
pressure;
SD, standard
deviation.
and
nitrate intake
from
vegetables
with IOP were not.

Figure
Graphicpresentation
presentation of
of the
the multivariable-adjusted
dose–response
relationship
between
Figure
1. 1.
Graphic
multivariable-adjusted
dose–response
relationship
between
incident open-angle glaucoma (iOAG), intraocular pressure (IOP), and energy adjusted dietary niincident open-angle glaucoma (iOAG), intraocular pressure (IOP), and energy adjusted dietary nitrate
trate intake obtained by generalized additive regression models; total dietary nitrate intake (A,D),
intake
obtained
by generalized
additive
models;
total dietary food
nitrate
intake(C,F).
(A,D),
nitrate
nitrate
intake from
vegetables (B,E),
and regression
nitrate intake
from non-vegetable
sources
Dotintake
fromrepresent
vegetables
(B,E),
and nitrate
intake
from
non-vegetable
food
sources
(C,F).with
Dotted
ted lines
95%
confidence
intervals.
The
reference
value is the
value
associated
the lines
mean nitrate
intake for all
participants.
rug plot
along
the value
x- andassociated
y-axis of each
graph
depicts
represent
95% confidence
intervals.
The The
reference
value
is the
with
the mean
nitrate
eachfor
observation.
intake
all participants. The rug plot along the x- and y-axis of each graph depicts each observation.

In the multivariable-adjusted model (Figure 2A; model 1), each 10 mg/day higher
total dietary nitrate intake was associated with a 5% reduction in the risk of iOAG (OR
(95% CI): 0.95 (0.91–0.98)). Participants in the highest quintile (Q5: mean 213.0 mg/day)
had the largest risk reduction (OR (95% CI): 0.38 (0.20–0.72)) compared to participants in
the lowest quintile (Q1: mean 48.8 mg/day) (p-trend = 0.002). For nitrate intake from veg-
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In the multivariable-adjusted model (Figure 2A; model 1), each 10 mg/day higher
total dietary nitrate intake was associated with a 5% reduction in the risk of iOAG (OR (95%
CI): 0.95 (0.91–0.98)). Participants in the highest quintile (Q5: mean 213.0 mg/day) had the
largest risk reduction (OR (95% CI): 0.38 (0.20–0.72)) compared to participants in the lowest
quintile (Q1: mean 48.8 mg/day) (p-trend = 0.002). For nitrate intake from vegetables,
we observed a 5% reduction in the risk of iOAG (OR (95% CI): 0.95 (0.91–0.98)) for each
10 mg/day higher intake (Figure 2B; model 1). The difference in iOAG risk was 61% when
7 of 14
comparing the highest (Q5: mean 196.8 mg/day) and lowest (Q1: mean 34.6 mg/day)
nitrate intake from vegetables (OR (95% CI): 0.39 (0.20–0.73)) (p-trend = 0.003). For nitrate
intake from non-vegetable food sources, we observed a 37% reduction in the risk of iOAG
we did
notCI):
observe
significant for
trend
(p-trend
= 0.08).higher
Additional
adjustment
of the
afore(OR
(95%
0.63 a(0.41–0.96))
each
10 mg/day
intake
(Figure 2C;
model
1),
mentioned
with
IOP (Figure
2; model
2) or
with education
and smoking
but we did analyses
not observe
a significant
trend
(p-trend
= 0.08).
Additionallevel
adjustment
of the
status
(Figure 2;analyses
model 3)with
did IOP
not change
results.
cumulative
folaforementioned
(Figure the
2; model
2) When
or withanalyzing
educationthe
level
and smoking
status (Figure
2; model
3) didintake
not change
the results.
analyzing
the cumulative
low-up
intervals,
a higher
of dietary
nitrateWhen
intake
was associated
with afollowlower
up intervals,
a higher
intake
of dietary
nitrate interval
intake was
with
a lower(Figure
iOAG
iOAG
risk during
every
cumulative
follow-up
afterassociated
10 years of
follow-up
risk during every cumulative follow-up interval after 10 years of follow-up (Figure S1).
S1).

Figure
Figure 2.
2. Odds
Odds ratios
ratios (95%
(95% confidence
confidence interval
interval (CI))
(CI)) for
for open-angle
open-angle glaucoma
glaucoma by
by total
total dietary
dietary nitrate
nitrate
intake
(A),
nitrate
intake
from
vegetables
(B),
and
nitrate
intake
from
non-vegetable
food
sources
intake (A), nitrate intake from vegetables (B), and nitrate intake from non-vegetable food sources
(C) (as continuous variables and quintiles) analyzed using conditional logistic regression. Model 1:
(C) (as continuous variables and quintiles) analyzed using conditional logistic regression. Model
adjusted for body mass index, total energy intake, diet quality, physical activity, and follow-up time.
1: adjusted for body mass index, total energy intake, diet quality, physical activity, and follow-up
Model 2: model 1 additionally adjusted for intraocular pressure. Model 3: model 1 additionally adtime. Model
2: modellevel
1 additionally
adjusted
justed
for education
and smoking
status.for intraocular pressure. Model 3: model 1 additionally
adjusted for education level and smoking status.

For IOP as outcome, we observed no significant associations with total dietary nitrate
For IOP as outcome, we observed no significant associations with total dietary nitrate
intake (beta (95% CI): 0.02 (−0.02–0.06) for each 10 mg/day higher intake) and nitrate intake
intake (beta (95% CI): 0.02 (−0.02–0.06) for each 10 mg/day higher intake) and nitrate
from vegetables (beta (95% CI): 0.02 (−0.02–0.06) for each 10 mg/day higher intake) (Table
3). We did observe a borderline significant association between nitrate intake from nonvegetable food sources and IOP (beta (95% CI): −0.45 (−0.96–0.06) for each 10 mg/day
higher intake) (p-trend = 0.09). We found no significant associations between dietary nitrate intake and diastolic blood pressure (Table S1) and systolic blood pressure (Table S2).
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intake from vegetables (beta (95% CI): 0.02 (−0.02–0.06) for each 10 mg/day higher intake)
(Table 3). We did observe a borderline significant association between nitrate intake
from non-vegetable food sources and IOP (beta (95% CI): −0.45 (−0.96–0.06) for each
10 mg/day higher intake) (p-trend = 0.09). We found no significant associations between
dietary nitrate intake and diastolic blood pressure (Table S1) and systolic blood pressure
(Table S2). Only nitrate intake from non-vegetable food sources was associated with a
lower risk of hypertension (OR (95% CI): 0.65 (0.45–0.94) for each 10 mg/day higher intake)
(p-trend = 0.06) (Table S3).
Table 3. Multivariable adjusted beta (95% confidence interval) of intraocular pressure (IOP), by
quintiles of nitrate intake.
Beta a per 1
Unit Increase

p-Value

Q1

Q2

Q3

Q4

Q5

p-Trend b

Model 1

0.02
(−0.02–0.06)

0.35

0.00

−0.04
(−0.89–0.80)

−0.25
(−1.05–0.55)

−0.22
(−0.98–0.53)

−0.15
(−0.99–0.69)

0.78

Model 2

0.02
(−0.02–0.06)

0.39

0.00

−0.02
(−0.87–0.83)

−0.30
(−1.11–0.50)

−0.23
(−0.99–0.54)

−0.20
(−1.06–0.66)

0.69

Nitrate intake from
vegetables
(10 mg/day)

Model 1

0.02
(−0.02–0.06)

0.29

0.00

0.33
(−0.48–1.13)

0.17
(−0.61–0.95)

−0.13
(−0.85–0.60)

0.11
(−0.69–0.91)

0.91

Model 2

0.02
(−0.02–0.06)

0.32

0.00

0.33
(−0.48–1.14)

0.18
(−0.61–0.97)

−0.12
(−0.85–0.62)

0.05
(−0.76–0.87)

0.82

Nitrate intake from
non-vegetable food
sources (10 mg/day)

Model 1

−0.45
(−0.96–0.06)

0.09

0.00

0.37
(−0.52–1.25)

0.05
(−0.73–0.84)

−0.15
(−0.92–0.62)

−0.29
(−1.05–0.47)

0.09

Model 2

−0.46
(−0.98–0.05)

0.08

0.00

0.37
(−0.53–1.26)

0.05
(−0.74–0.84)

−0.18
(−0.96–0.60)

−0.31
(−1.08–0.45)

0.08

Total dietary nitrate
intake
(10 mg/day)

Model 1: adjusted for body mass index, total energy intake, diet quality, physical activity, and follow-up time.
Model 2: model 1 additionally adjusted for education level and smoking status. a Betas (95%CI) for intraocular
pressure (IOP) by total dietary nitrate intake, nitrate intake from vegetables, and nitrate intake from non-vegetable
food sources (as continuous variables) analyzed using linear regression. b Test for trend conducted using median
value for each quintile (total dietary nitrate intake: quintile 1 = 48.8 mg/day; quintile 2 = 69.0 mg/day; quintile
3 = 86.4 mg/day; quintile 4 = 114.0 mg/day; quintile 5 = 213.0 mg/day; nitrate intake from vegetables: quintile
1 = 34.6 mg/day; quintile 2 = 54.2 mg/day; quintile 3 = 72.0 mg/day; quintile 4 = 98.1 mg/day; quintile 5 =
196.8 mg/day; nitrate intake from non-vegetable food sources: quintile 1 = 10.1 mg/day; quintile 2 = 11.9 mg/day;
quintile 3 = 14.1 mg/day; quintile 4 = 15.8 mg/day; quintile 5 = 21.1 mg/day).

4. Discussion
In this case–control study embedded within a prospective population-based cohort,
we found that dietary nitrate intake showed a strong association with a decreased incidence
of OAG. No significant associations were observed between dietary nitrate intake and IOP.
Additionally, no clear associations were observed between dietary nitrate intake and blood
pressure.
To our knowledge, we are the first to assess the association between dietary nitrate and
iOAG, stratified by source (vegetables vs. non-vegetable food sources). The Nurses’ Health
Study and the Health Professionals Follow-up Study reported a pooled multivariable rate
ratio (MVRR) of 0.79 (95% CI 0.66–0.93; p-trend = 0.02) for the highest quintile of dietary
nitrate intake (~240 mg/day) as compared with the lowest quintile (~80 mg/day) [3]. When
additionally adjusted for other dietary factors, this pooled MVRR decreased to 0.67 (95%
CI 0.52–0.85; p-trend = 0.01) [3]. We found a similar result and trend. A nitrate intake
of ~200 mg can be achieved by consuming 100 g spinach (nitrate: 1926 mg/kg), 130 g
beets (nitrate: 1581 mg/kg), 190 g endive (nitrate: 1054 mg/kg) or 115 g kale (nitrate:
1748 mg/kg) [40]. These are very feasible portion sizes, as the Dutch dietary guidelines
recommend consuming at least 200 g of vegetables daily [43]. As we did not observe an
association between dietary nitrate intake and IOP, the association between dietary nitrate
and iOAG may be explained by other, IOP-independent, mechanisms.
Dietary nitrate intake may affect the risk of iOAG due to its beneficial effects on blood
pressure, endothelial function, reperfusion injury, and platelet aggregation (Figure S2).
These effects are likely to occur as a result of enhanced NO production through the nitrate–
nitrite–NO pathway [22]. Previous research has shown that a higher dietary nitrate intake
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was associated with significantly wider retinal arterioles [46]. Widening of retinal arteriolar
caliber is not only associated with a lower risk of cardiovascular and cerebrovascular
diseases [47,48], but also with a lower risk of glaucoma [49]. Eyes with primary OAG
were 2.7 times more likely to have generalized arteriolar narrowing, and narrower retinal
arterioles were significantly associated with higher OAG prevalence and incidence [50–54].
Thus, the association between nitrate and OAG may be explained by increased retinal
arteriolar caliber caused by nitrate, which affects blood pressure. Previous population-based
studies have suggested that IOP is associated with systemic blood pressure levels [55–64].
Nevertheless, in our study, we found no clear association between dietary nitrate intake
and IOP or blood pressure.
Although research into the IOP-independent pathways by which dietary nitrate intake
could influence glaucoma incidence are limited, we would like to highlight their potential
in explaining in part or in combination the inverse association found in this study. Endothelial dysfunction in glaucoma has been associated with an imbalance between endothelin-1
and NO [65]. Dietary nitrate could thus potentially lower the incidence of OAG by upregulating the NO levels, hereby improving endothelial function. Glaucomatous retinal
ganglion cell loss has previously been associated with increased oxidant levels [66–69], a
theory that is supported by the fact that administration of antioxidants protects retinal
cells from injury following retinal ischemia and reperfusion [70–73]. Retinal ischemia can
thus potentially impact optic nerve degeneration [74]. Increased NO bioavailability acts on
the balance between antioxidants and prooxidant agents [75]. NO can eliminate oxidants,
reduce equivalents provided by superoxide, and prevent the reaction of peroxide [76].
Dietary nitrate has shown to suppress radical formation and to be a scavenger of potentially damaging reactive oxygen and nitrogen species, suggesting that it may also exhibit
antioxidant effects [76,77]. This is one mechanism that may play a role in the observed
association between dietary nitrate intake and iOAG. Moreover, adhesion and aggregation
of platelets is inhibited by NO. Modulation of platelet function is an important therapeutic
strategy in preventing and treating atherosclerosis, a disease considered to increase glaucoma risk [78,79]. Thus, mediation of platelet aggregation is one other mechanism that
could underlie the association between dietary nitrate intake and iOAG.
This study has several strengths. We used a prospective population-based design,
allowing repeated eye examinations, and thus prospectively ascertaining iOAG cases,
according to a well-established OAG definition [28] and IOP measurements. Additionally,
dietary data were collected using validated FFQs, which included a wide variety of food
items commonly consumed in the Dutch population. By using dietary information from
baseline assessments, we limited selection bias and the risk of reverse causality, since all
included participants were free of iOAG at this visit. Moreover, the questionnaire was
administered to cases and controls under similar conditions. Furthermore, we assessed the
association between dietary nitrate intake and iOAG over cumulative follow-up periods
to provide insight into possible reversed causality. The persistence of the association over
time implies that reverse causality is unlikely. The availability of robust data on possible
confounders allowed us to reach an independent association between dietary nitrate intake
and iOAG. Given that our cases and controls were matched on age and sex, it is very
unlikely that our findings were affected by the association of age and sex with dietary
(nitrate) intake. We performed additional matching on BMI (with a range of 2.0 kg/m2 ),
since the controls in this study had a significantly higher BMI than the iOAG cases, and a
higher BMI appears to be associated with lower iOAG risk [80–85]. However, additional
matching on BMI did not change the association between dietary nitrate intake and iOAG
or IOP (Tables S4 and S5, respectively). Limitations should also be considered when
interpreting our results. By assessing the association in time, thus only looking at incident
disease, we limited the number of iOAG cases, and therefore also IOP measurements.
As the iOAG cases did not have exorbitant IOP measurements typically associated with
OAG (mean 16.2 mmHg; interquartile range 13–18 mmHg), this may have limited our
possibilities to detect statistically significant IOP-lowering effects of dietary nitrate intake.
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By using the FFQ, we relied on the participants’ memory for collecting information for as far
back as one month. Additionally, the FFQ is known to under- or over-report certain foods,
leading to non-differential misclassification. Additionally, based on the FFQs, nitrate intake
over the past year or month was determined, which does not per definition reflect long
term intake as participants may change dietary habits over time. However, since dietary
information was collected at baseline, with all participants free of iOAG, it is unlikely
that such misclassification would result in false-positive findings. If glaucoma presence
would have an effect on dietary nitrate intake, this would not be applicable to our study.
Despite the limitations, the low respondent burden makes the FFQ an easy and effective
data collection tool. It additionally allows for calculation of the total energy intake, which
is a large benefit [86]. Although the analyses were adjusted for multiple confounders, we
were unable to adjust for other possible confounders such as family history of glaucoma,
since this was only available for a small subset of participants. We did consider the risk
factor myopia, for which we adjusted by including education level into model 3. We also
included spherical equivalent into the model (data not shown), but this did not change
the results. Lastly, residual confounding cannot completely be excluded. In summary, a
higher dietary nitrate intake reduces the risk of iOAG. The effect was independent of the
IOP. Our findings confirm earlier reported associations between dietary nitrate intake and
OAG. However, intervention studies are necessary before the association between dietary
nitrate intake and iOAG can be considered as an important public health implication.
Supplementary Materials: The following supporting information can be downloaded at: https://
www.mdpi.com/article/10.3390/nu14122490/s1, Figure S1: Multivariable-adjusted odds ratios with
corresponding 95% confidence intervals (CIs) for incident open-angle glaucoma per 10 g/day increase
in total dietary nitrate intake (A), nitrate intake from vegetables (B), and nitrate intake from nonvegetable food sources (C), shown per cumulative follow-up interval; Table S1: Multivariable adjusted
beta (95% confidence interval) of diastolic blood pressure, by quintiles of nitrate intake; Table S2:
Multivariable adjusted beta (95% confidence interval) of systolic blood pressure, by quintiles of nitrate
intake; Table S3: Multivariable adjusted odds ratio (95% confidence interval) of hypertension, by
quintiles of nitrate intake; Figure S2: Beneficial health effects of dietary nitrate; Table S4: Multivariable
adjusted odds ratio (95% confidence interval) of incident open-angle glaucoma by nitrate intake;
Table S5: Multivariable adjusted beta (95% confidence interval) of intraocular pressure by nitrate
intake.
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in Leafy Green Vegetables and Estimated Intake. Afr. J. Tradit. Complement. Altern. Med. 2017, 14, 31–41.
Sweazea, K.L.; Johnston, C.S.; Miller, B.; Gumpricht, E. Nitrate-Rich Fruit and Vegetable Supplement Reduces Blood Pressure in
Normotensive Healthy Young Males without Significantly Altering Flow-Mediated Vasodilation: A Randomized, Double-Blinded,
Controlled Trial. J. Nutr. Metab. 2018, 2018, 1729653. [CrossRef]
Iammarino, M.; Di Taranto, A.; Cristino, M. Monitoring of nitrites and nitrates levels in leafy vegetables (spinach and lettuce): A
contribution to risk assessment. J. Sci. Food Agric. 2014, 94, 773–778. [CrossRef]
Morris, M.C.; Wang, Y.; Barnes, L.L.; Bennett, D.A.; Dawson-Hughes, B.; Booth, S.L. Nutrients and bioactives in green leafy
vegetables and cognitive decline: Prospective study. Neurology 2018, 90, e214–e222. [CrossRef]
Bauer, V.; Sotníková, R. Nitric oxide—The endothelium-derived relaxing factor and its role in endothelial functions. Gen. Physiol.
Biophys. 2010, 29, 319–340. [CrossRef]
Saccà, S.C.; Gandolfi, S.; Bagnis, A.; Manni, G.; Damonte, G.; Traverso, C.E.; Izzotti, A. The Outflow Pathway: A Tissue with
Morphological and Functional Unity. J. Cell. Physiol. 2016, 231, 1876–1893. [CrossRef] [PubMed]
Dismuke, W.M.; Mbadugha, C.C.; Ellis, D.Z. NO-induced regulation of human trabecular meshwork cell volume and aqueous
humor outflow facility involve the BKCa ion channel. Am. J. Physiol. Cell Physiol. 2008, 294, C1378–C1386. [CrossRef] [PubMed]
Stamer, W.D.; Lei, Y.; Boussommier-Calleja, A.; Overby, D.R.; Ethier, C.R. eNOS, a pressure-dependent regulator of intraocular
pressure. Investig. Ophthalmol. Vis. Sci. 2011, 52, 9438–9444. [CrossRef] [PubMed]
Galassi, F.; Renieri, G.; Sodi, A.; Ucci, F.; Vannozzi, L.; Masini, E. Nitric oxide proxies and ocular perfusion pressure in primary
open angle glaucoma. Br. J. Ophthalmol. 2004, 88, 757–760. [CrossRef]
Lidder, S.; Webb, A.J. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric
oxide pathway. Br. J. Clin. Pharmacol. 2013, 75, 677–696. [CrossRef]
Doganay, S.; Evereklioglu, C.; Turkoz, Y.; Er, H. Decreased nitric oxide production in primary open-angle glaucoma. Eur. J.
Ophthalmol. 2002, 12, 44–48. [CrossRef]
Kotikoski, H.; Vapaatalo, H.; Oksala, O. Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits. Curr.
Eye Res. 2003, 26, 119–123. [CrossRef]
Borghi, V.; Bastia, E.; Guzzetta, M.; Chiroli, V.; Toris, C.B.; Batugo, M.R.; Carreiro, S.T.; Chong, W.K.; Gale, D.C.; Kucera, D.J.; et al.
A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of
glaucoma. J. Ocul. Pharmacol. Ther. 2010, 26, 125–132. [CrossRef]
Mäepea, O.; Bill, A. The pressures in the episcleral veins, Schlemm’s canal and the trabecular meshwork in monkeys: Effects of
changes in intraocular pressure. Exp. Eye Res. 1989, 49, 645–663. [CrossRef]
Mäepea, O.; Bill, A. Pressures in the juxtacanalicular tissue and Schlemm’s canal in monkeys. Exp. Eye Res. 1992, 54, 879–883.
[CrossRef]

Nutrients 2022, 14, 2490

21.
22.
23.

24.
25.
26.
27.
28.
29.

30.

31.

32.
33.
34.
35.

36.
37.
38.
39.
40.

41.

42.
43.

44.

45.

12 of 14

Ashpole, N.E.; Overby, D.R.; Ethier, C.R.; Stamer, W.D. Shear stress-triggered nitric oxide release from Schlemm’s canal cells.
Investig. Ophthalmol. Vis. Sci. 2014, 55, 8067–8076. [CrossRef] [PubMed]
Bondonno, C.P.; Croft, K.D.; Hodgson, J.M. Dietary nitrate, nitric oxide, and cardiovascular health. Crit. Rev. Food Sci. Nutr. 2016,
56, 2036–2052. [CrossRef] [PubMed]
Ikram, M.A.; Brusselle, G.G.O.; Murad, S.D.; van Duijn, C.M.; Franco, O.H.; Goedegebure, A.; Klaver, C.C.W.; Nijsten, T.E.C.;
Peeters, R.P.; Stricker, B.H.; et al. The Rotterdam Study: 2018 update on objectives, design and main results. Eur. J. Epidemiol.
2017, 32, 807–850. [CrossRef] [PubMed]
Coleman, A.L.; Miglior, S. Risk factors for glaucoma onset and progression. Surv. Ophthalmol. 2008, 53 (Suppl. 1), S3–S10.
[CrossRef] [PubMed]
Drewnowski, A.; Shultz, J.M. Impact of aging on eating behaviors, food choices, nutrition, and health status. J. Nutr. Health Aging
2001, 5, 75–79. [PubMed]
Hiza, H.A.; Casavale, K.O.; Guenther, P.M.; Davis, C.A. Diet quality of Americans differs by age, sex, race/ethnicity, income, and
education level. J. Acad. Nutr. Diet. 2013, 113, 297–306. [CrossRef]
Grzymisławska, M.; Puch, E.A.; Zawada, A.; Grzymisławski, M. Do nutritional behaviors depend on biological sex and cultural
gender? Adv. Clin. Exp. Med. 2020, 29, 165–172. [CrossRef]
Springelkamp, H.; Wolfs, R.C.; Ramdas, W.D.; Hofman, A.; Vingerling, J.R.; Klaver, C.C.; Jansonius, N.M. Incidence of glaucomatous visual field loss after two decades of follow-up: The Rotterdam Study. Eur. J. Epidemiol. 2017, 32, 691–699. [CrossRef]
Dielemans, I.; Vingerling, J.R.; Hofman, A.; Grobbee, D.E.; de Jong, P.T. Reliability of intraocular pressure measurement with the
Goldmann applanation tonometer in epidemiological studies. Graefes Arch. Clin. Exp. Ophthalmol. 1994, 232, 141–144. [CrossRef]
[PubMed]
Ikram, M.A.; Brusselle, G.; Ghanbari, M.; Goedegebure, A.; Ikram, M.K.; Kavousi, M.; Kieboom, B.C.T.; Klaver, C.C.W.; de Knegt,
R.J.; Luik, A.I.; et al. Objectives, design and main findings until 2020 from the Rotterdam Study. Eur. J. Epidemiol. 2020, 35,
483–517. [CrossRef]
Klipstein-Grobusch, K.; den Breeijen, J.H.; Goldbohm, R.A.; Geleijnse, J.M.; Hofman, A.; Grobbee, D.E.; Witteman, J.C. Dietary
assessment in the elderly: Validation of a semiquantitative food frequency questionnaire. Eur. J. Clin. Nutr. 1998, 52, 588–596.
[CrossRef] [PubMed]
Goldbohm, R.A.; van den Brandt, P.A.; Brants, H.A.; van’t Veer, P.; Al, M.; Sturmans, F.; Hermus, R.J. Validation of a dietary
questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur. J. Clin. Nutr. 1994, 48, 253–265. [PubMed]
Feunekes, G.I.; Van Staveren, W.A.; De Vries, J.H.; Burema, J.; Hautvast, J.G. Relative and biomarker-based validity of a
food-frequency questionnaire estimating intake of fats and cholesterol. Am. J. Clin. Nutr. 1993, 58, 489–496. [CrossRef] [PubMed]
Bogovski, P.; Bogovski, S. Special report animal species in which n-nitroso compounds induce cancer. Int. J. Cancer 1981, 27,
471–474. [CrossRef]
Keszei, A.P.; Goldbohm, R.A.; Schouten, L.J.; Jakszyn, P.; van den Brandt, P.A. Dietary N-nitroso compounds, endogenous
nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Am. J. Clin. Nutr. 2013, 97,
135–146. [CrossRef]
Knekt, P.; Järvinen, R.; Dich, J.; Hakulinen, T. Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite
and N-nitroso compounds: A follow-up study. Int. J. Cancer 1999, 80, 852–856. [CrossRef]
Aschebrook-Kilfoy, B.; Ward, M.H.; Gierach, G.L.; Schatzkin, A.; Hollenbeck, A.R.; Sinha, R.; Cross, A.J. Epithelial ovarian cancer
and exposure to dietary nitrate and nitrite in the NIH-AARP Diet and Health Study. Eur. J. Cancer Prev. 2012, 21, 65–72. [CrossRef]
Cross, A.J.; Freedman, N.D.; Ren, J.; Ward, M.H.; Hollenbeck, A.R.; Schatzkin, A.; Sinha, R.; Abnet, C.C. Meat consumption and
risk of esophageal and gastric cancer in a large prospective study. Am. J. Gastroenterol. 2011, 106, 432–442. [CrossRef]
Dellavalle, C.T.; Daniel, C.R.; Aschebrook-Kilfoy, B.; Hollenbeck, A.R.; Cross, A.J.; Sinha, R.; Ward, M.H. Dietary intake of nitrate
and nitrite and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Br. J. Cancer 2013, 108, 205–212. [CrossRef]
Blekkenhorst, L.C.; Prince, R.L.; Ward, N.C.; Croft, K.D.; Lewis, J.R.; Devine, A.; Shinde, S.; Woodman, R.J.; Hodgson, J.M.;
Bondonno, C.P. Development of a reference database for assessing dietary nitrate in vegetables. Mol. Nutr. Food Res. 2017, 61,
1600982. [CrossRef]
Inoue-Choi, M.; Virk-Baker, M.K.; Aschebrook-Kilfoy, B.; Cross, A.J.; Subar, A.F.; Thompson, F.E.; Sinha, R.; Ward, M.H.
Development and calibration of a dietary nitrate and nitrite database in the NIH-AARP Diet and Health Study. Public Health Nutr.
2016, 19, 1934–1943. [CrossRef] [PubMed]
ATC/DDD Index 2022. Available online: https://www.whocc.no/atc_ddd_index/ (accessed on 14 June 2022).
Voortman, T.; Kiefte-de Jong, J.C.; Ikram, M.A.; Stricker, B.H.; van Rooij, F.J.A.; Lahousse, L.; Tiemeier, H.; Brusselle, G.G.; Franco,
O.H.; Schoufour, J.D. Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in
the Rotterdam Study. Eur. J. Epidemiol. 2017, 32, 993–1005. [CrossRef] [PubMed]
Caspersen, C.J.; Bloemberg, B.P.; Saris, W.H.; Merritt, R.K.; Kromhout, D. The prevalence of selected physical activities and their
relation with coronary heart disease risk factors in elderly men: The Zutphen Study, 1985. Am. J. Epidemiol. 1991, 133, 1078–1092.
[CrossRef]
Stel, V.S.; Smit, J.H.; Pluijm, S.M.; Visser, M.; Deeg, D.J.; Lips, P. Comparison of the LASA Physical Activity Questionnaire with a
7-day diary and pedometer. J. Clin. Epidemiol. 2004, 57, 252–258. [CrossRef] [PubMed]

Nutrients 2022, 14, 2490

46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.

58.
59.
60.
61.
62.

63.
64.

65.
66.
67.
68.
69.
70.
71.
72.
73.

13 of 14

Gopinath, B.; Liew, G.; Lewis, J.R.; Blekkenhorst, L.C.; Bondonno, C.; Burlutsky, G.; Hodgson, J.M.; Mitchell, P. Association of
dietary nitrate intake with retinal microvascular structure in older adults. Eur. J. Nutr. 2020, 59, 2057–2063. [CrossRef]
McGeechan, K.; Liew, G.; Macaskill, P.; Irwig, L.; Klein, R.; Klein, B.E.K.; Wang, J.J.; Mitchell, P.; Vingerling, J.R.; DeJong, P.T.V.M.
Meta-analysis: Retinal vessel caliber and risk for coronary heart disease. Ann. Intern. Med. 2009, 151, 404–413. [CrossRef]
Ikram, M.K.; De Jong, F.J.; Bos, M.J.; Vingerling, J.R.; Hofman, A.; Koudstaal, P.J.; De Jong, P.; Breteler, M.M.B. Retinal vessel
diameters and risk of stroke: The Rotterdam Study. Neurology 2006, 66, 1339–1343. [CrossRef]
Chan, K.K.W.; Tang, F.; Tham, C.C.Y.; Young, A.L.; Cheung, C.Y. Retinal vasculature in glaucoma: A review. BMJ Open Ophthalmol.
2017, 1, e000032. [CrossRef]
Mitchell, P.; Leung, H.; Wang, J.J.; Rochtchina, E.; Lee, A.J.; Wong, T.Y.; Klein, R. Retinal vessel diameter and open-angle glaucoma:
The Blue Mountains Eye Study. Ophthalmology 2005, 112, 245–250. [CrossRef]
Kawasaki, R.; Wang, J.J.; Rochtchina, E.; Lee, A.J.; Wong, T.Y.; Mitchell, P. Retinal vessel caliber is associated with the 10-year
incidence of glaucoma: The Blue Mountains Eye Study. Ophthalmology 2013, 120, 84–90. [CrossRef]
Amerasinghe, N.; Aung, T.; Cheung, N.; Fong, C.W.; Wang, J.J.; Mitchell, P.; Saw, S.M.; Wong, T.Y. Evidence of retinal vascular
narrowing in glaucomatous eyes in an Asian population. Investig. Ophthalmol. Vis. Sci. 2008, 49, 5397–5402. [CrossRef] [PubMed]
Wang, S.; Xu, L.; Wang, Y.; Wang, Y.; Jonas, J.B. Retinal vessel diameter in normal and glaucomatous eyes: The Beijing eye study.
Clin. Exp. Ophthalmol. 2007, 35, 800–807. [CrossRef] [PubMed]
Yoo, E.; Yoo, C.; Lee, B.R.; Lee, T.E.; Kim, Y.Y. Diagnostic Ability of Retinal Vessel Diameter Measurements in Open-Angle
Glaucoma. Investig. Ophthalmol. Vis. Sci. 2015, 56, 7915–7922. [CrossRef] [PubMed]
Bengtsson, B. Some factors affecting the distribution of intraocular pressures in a population. Acta Ophthalmol. 1972, 50, 33–46.
[CrossRef]
Bulpitt, C.J.; Hodes, C.; Everitt, M.G. Intraocular pressure and systemic blood pressure in the elderly. Br. J. Ophthalmol. 1975, 59,
717–720. [CrossRef]
Kahn, H.A.; Leibowitz, H.M.; Ganley, J.P.; Kini, M.M.; Colton, T.; Nickerson, R.S.; Dawber, T.R. The Framingham Eye Study. II.
Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am. J. Epidemiol.
1977, 106, 33–41. [CrossRef]
Klein, B.E.; Klein, R. Intraocular pressure and cardiovascular risk variables. Arch. Ophthalmol. 1981, 99, 837–839. [CrossRef]
Klein, B.E.; Klein, R.; Linton, K.L. Intraocular pressure in an American community. The Beaver Dam Eye Study. Investig.
Ophthalmol. Vis. Sci. 1992, 33, 2224–2228.
Wu, S.Y.; Leske, M.C. Associations with intraocular pressure in the Barbados Eye Study. Arch. Ophthalmol. 1997, 115, 1572–1576.
[CrossRef]
Tielsch, J.M.; Katz, J.; Sommer, A.; Quigley, H.A.; Javitt, J.C. Hypertension, perfusion pressure, and primary open-angle glaucoma.
A population-based assessment. Arch. Ophthalmol. 1995, 113, 216–221. [CrossRef]
Dielemans, I.; Vingerling, J.R.; Algra, D.; Hofman, A.; Grobbee, D.E.; de Jong, P.T. Primary open-angle glaucoma, intraocular
pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995, 102, 54–60.
[CrossRef]
Healey, P.R.; Mitchell, P.; Smith, W.; Wang, J.J. The influence of age and intraocular pressure on the optic cup in a normal
population. J. Glaucoma 1997, 6, 274–278. [CrossRef] [PubMed]
Foster, P.J.; Machin, D.; Wong, T.Y.; Ng, T.P.; Kirwan, J.F.; Johnson, G.J.; Khaw, P.T.; Seah, S.K. Determinants of intraocular pressure
and its association with glaucomatous optic neuropathy in Chinese Singaporeans: The Tanjong Pagar Study. Investig. Ophthalmol.
Vis. Sci. 2003, 44, 3885–3891. [CrossRef]
Resch, H.; Garhofer, G.; Fuchsjäger-Mayrl, G.; Hommer, A.; Schmetterer, L. Endothelial dysfunction in glaucoma. Acta Ophthalmologica 2009, 87, 4–12. [CrossRef]
McMonnies, C. Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy. J. Optom. 2018, 11, 3–9.
[CrossRef]
Kumar, D.M.; Agarwal, N. Oxidative stress in glaucoma: A burden of evidence. J. Glaucoma 2007, 16, 334–343. [CrossRef]
Ferreira, S.M.; Lerner, S.F.; Brunzini, R.; Evelson, P.A.; Llesuy, S.F. Oxidative stress markers in aqueous humor of glaucoma
patients. Am. J. Ophthalmol. 2004, 137, 62–69. [CrossRef]
Izzotti, A.; Saccà, S.C.; Cartiglia, C.; De Flora, S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am. J.
Med. 2003, 114, 638–646. [CrossRef]
Chidlow, G.; Schmidt, K.G.; Wood, J.P.; Melena, J.; Osborne, N.N. Alpha-lipoic acid protects the retina against ischemia-reperfusion.
Neuropharmacology 2002, 43, 1015–1025. [CrossRef]
Pan, H.; He, M.; Liu, R.; Brecha, N.C.; Yu, A.C.; Pu, M. Sulforaphane protects rodent retinas against ischemia-reperfusion injury
through the activation of the Nrf2/HO-1 antioxidant pathway. PLoS ONE 2014, 9, e114186. [CrossRef]
Xu, Y.P.; Han, F.; Tan, J. Edaravone protects the retina against ischemia/reperfusion-induced oxidative injury through the
PI3K/Akt/Nrf2 pathway. Mol. Med. Rep. 2017, 16, 9210–9216. [CrossRef] [PubMed]
Seong, H.; Ryu, J.; Yoo, W.S.; Kim, S.J.; Han, Y.S.; Park, J.M.; Kang, S.S.; Seo, S.W. Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3. Curr. Eye Res. 2017, 42, 1650–1658. [CrossRef]
[PubMed]

Nutrients 2022, 14, 2490

74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.

14 of 14

Renner, M.; Stute, G.; Alzureiqi, M.; Reinhard, J.; Wiemann, S.; Schmid, H.; Faissner, A.; Dick, H.B.; Joachim, S.C. Optic Nerve
Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model. Front. Cell. Neurosci. 2017, 11, 254. [CrossRef] [PubMed]
Félétou, M.; Vanhoutte, P.M. Endothelium-derived hyperpolarizing factor: Where are we now? Arterioscler. Thromb. Vasc. Biol.
2006, 26, 1215–1225. [CrossRef]
Wink, D.A.; Miranda, K.M.; Espey, M.G.; Pluta, R.M.; Hewett, S.J.; Colton, C.; Vitek, M.; Feelisch, M.; Grisham, M.B. Mechanisms
of the antioxidant effects of nitric oxide. Antioxid. Redox Signal. 2001, 3, 203–213. [CrossRef]
Clifford, T.; Howatson, G.; West, D.J.; Stevenson, E.J. The potential benefits of red beetroot supplementation in health and disease.
Nutrients 2015, 7, 2801–2822. [CrossRef]
Song, X.; Li, P.; Li, Y.; Yan, X.; Yuan, L.; Zhao, C.; An, Y.; Chang, X. Strong association of glaucoma with atherosclerosis. Sci. Rep.
2021, 11, 8792. [CrossRef]
Song, X.; Li, P.; Yuan, L.; Li, Y.; Yan, X.; Zhao, C.; An, Y.; Chang, X. Strong Association of Glaucoma with Atherosclerosis and
Potential Therapeutic Effect of Methazolamide on Atherosclerosis. Res. Sq. 2021, 1–13. [CrossRef]
Lin, S.C.; Pasquale, L.R.; Singh, K.; Lin, S.C. The Association between Body Mass Index and Open-angle Glaucoma in a South
Korean Population-based Sample. J. Glaucoma 2018, 27, 239–245. [CrossRef]
Ramdas, W.D.; Wolfs, R.C.; Hofman, A.; de Jong, P.T.; Vingerling, J.R.; Jansonius, N.M. Lifestyle and risk of developing open-angle
glaucoma: The Rotterdam study. Arch. Ophthalmol. 2011, 129, 767–772. [CrossRef]
Na, K.-S.; Kim, J.-H.; Paik, J.-S.; Cho, W.-K.; Ha, M.; Park, Y.-G.; Yang, S.-W. Underweight increases the risk of primary open-angle
glaucoma in diabetes patients: A Korean nationwide cohort study. Medicine 2020, 99, e19285. [CrossRef] [PubMed]
Kim, A.Y.; Han, K.E.; Jun, R.M.; Choi, K.R. Progression of Visual Field Loss and Body Mass Index in Normal Tension Glaucoma. J.
Korean Ophthalmol. Soc. 2017, 58, 1404–1409. [CrossRef]
Berdahl, J.P.; Fleischman, D.; Zaydlarova, J.; Stinnett, S.; Allingham, R.R.; Fautsch, M.P. Body Mass Index Has a Linear Relationship
with Cerebrospinal Fluid Pressure. Investig. Ophthalmol. Vis. Sci. 2012, 53, 1422–1427. [CrossRef] [PubMed]
Fleischman, D.; Berdahl, J.P.; Zaydlarova, J.; Stinnett, S.; Fautsch, M.P.; Allingham, R.R. Cerebrospinal fluid pressure decreases
with older age. PLoS ONE 2012, 7, e52664. [CrossRef] [PubMed]
Willett, W.; Stampfer, M.J. Total energy intake: Implications for epidemiologic analyses. Am. J. Epidemiol. 1986, 124, 17–27.
[CrossRef]

